title: Rare Disease Therapeutics Market to Surpass US$ 495.27 Billion by 2033 as Gene Therapy, RNA-based Drugs, and Biologics Transform Patient Care
source: Yahoo
date: 2025-10-07
url: https://finnhub.io/api/news?id=ab39f8c16abd6bdfd8fb32b918f3a235397f60cf757e7ef69d08d758c0116eeb
The Rare Disease Therapeutics Market is experiencing an unprecedented wave of innovation, driven by gene therapies, RNA-based treatments, enzyme replacement therapies (ERTs), and targeted biologics. According to DataM Intelligence, the Rare Disease Therapeutics Market Size reached US$ 135.88 billion in 2023, rose to US$ 154.64 billion in 2024, and is projected to reach US$ 495.27 billion by 2033, expanding at a CAGR of 13.8% during 2025â€“2033.
